ClinConnect ClinConnect Logo
Search / Trial NCT01355887

A Trial to Compare Pringle Maneuver With Either Infrahepatic Inferior Vena Cava Clamping or Low Central Venous Pressure

Launched by HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY · May 17, 2011

Trial Information

Current as of July 24, 2025

Unknown status

Keywords

Blood Loss Hepatectomy Prospective Study Ptc

ClinConnect Summary

To better comprehend the benefits and efficacy of portal triad clamping with infrahepatic IVC clamping during complex hepatectomy. A randomized comparative trial was performed to compare PTC with either infrahepatic IVC clamping or low central venous pressure in complex liver resections. 192 consecutive patients were involved in this study and allocated equally to two groups. Preoperative demographic and clinical data, details of surgical procedure, pathologic diagnosis, postoperative course and complications were collected prospectively.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. patients who were assessed by preoperative medical imagings to have a high risk of backflow bleeding from the major hepatic veins and the IVC, based on the size and location of the tumor. The tumors were ≥5 cm in diameter and they involved the liver segments 7, 8 and/or the cranial portion of segment 4. These tumors were in close proximity or were compressing, but had not actually invaded, the major hepatic veins or IVC
  • 2. Pugh-Child Grade A
  • 3. Indocyanine green retention rate at 15 minutes (ICGR15) \< 10%;
  • 4. acceptable clotting profile (platelet count ≥ 50 ×109/L and prothrombin activity ≥ 60%)
  • 5. no previous liver resection.
  • Exclusion Criteria:
  • 1. extrahepatic metastases in patients with malignancy;
  • 2. patients who refused to take part in this study.

About Huazhong University Of Science And Technology

Huazhong University of Science and Technology (HUST) is a prestigious research university located in Wuhan, China, renowned for its commitment to advancing scientific knowledge and innovation in various fields, including medicine and healthcare. With a strong emphasis on interdisciplinary collaboration, HUST engages in cutting-edge clinical research aimed at improving patient outcomes and driving advancements in medical science. The university's clinical trial initiatives are supported by state-of-the-art facilities and a team of experienced researchers, making it a key player in the development of novel therapies and treatment strategies in the healthcare sector.

Locations

Wuhan, Hubei, China

Patients applied

0 patients applied

Trial Officials

Xiaoping Chen, Doctor

Study Director

Hepatic Surgery Center, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan, China

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials